主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
COCP
#3809
Cocrystal Pharma, Inc. Common Stock
1.0
4
-2.80%
版块:
基础:
利润货币:
日范围
年范围
日变化
-2.80%
每月变动
0.00%
6个月变化
-31.58%
年变化
-40.23%
前一天收盘价
1.0
7
Open
1.0
2
Bid
Ask
Low
1.0
2
High
1.0
4
交易量
7
市场
股票
医疗保健
COCP
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
10.17 M
10.17 M
10.17 M
10.26 M
13.78 M
—
Valuation ratios
Enterprise value
4.89 M
10.69 M
7.53 M
10.52 M
9.5 M
38.24 M
Price to earnings ratio
-0.97
-1.17
-0.91
-1.21
-1.34
-4.64
Price to sales ratio
-113.46
-126.08
-81.16
-76.18
-67.12
-350.54
Price to cash flow ratio
-1.06
-1.25
-0.97
-1.13
-1.33
-4.68
Price to book ratio
0.22
2.16
0.31
0.43
0.43
3.33
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.3
0.24
-0.22
0.24
0.2
0.46
Return on equity %
0.39
0.34
-0.32
0.39
0.27
0.68
Return on invested capital %
—
373.03
—
—
—
—
Gross margin %
100
100
100
100
100
400
Operating margin %
63.03 K
-1 374.47
78.03 K
8 432
11.61 K
96.7 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
61.74 K
-1 388.09
-76.7 K
8 220
11.38 K
-58.48 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
7.32
4.77
4.57
3.69
5.78
18.81
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
-0.02
0
0
0
-0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-2.12
0.31
-0.29
-0.21
-0.12
-0.31
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
1.28
0.97
0.68
0.47
0.7
2.82
Net current asset value per share
1.4
1.14
0.87
0.66
0.8
3.47
Tangible book value per share
1.25
0.94
0.72
0.52
0.7
2.88
Working capital per share
1.21
0.9
0.68
0.48
0.66
2.72
Book value per share
1.25
0.94
0.72
0.52
0.7
2.88
新闻
Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial
Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB
菲利普·弗罗斯特购入价值18,812美元的Cocrystal Pharma (COCP)股票
Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812
Cocrystal Pharma raises $1.03 million in private placement from directors
Cocrystal Pharma receives $500,000 NIH grant for influenza drug
Cocrystal Pharma完成470万美元的注册直接发行
Cocrystal Pharma closes $4.7 million registered direct offering
Cocrystal Pharma通过定向增发筹集470万美元资金
Cocrystal Pharma raises $4.7 million in registered direct offering
Cocrystal的诺如病毒药物CDI-988进入1b期研究
Cocrystal’s norovirus drug CDI-988 advances to phase 1b study